BIOLASE, Inc.
USD0.02
+0.00 (+27.39%)
CEO
John R. Beaver
IPO Date
1992-11-12
Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ
Country
US
Open
$0.05
Prev. Close
$0.02
Day Low
$0.02
Day High
$0.05
52W Low
$0.02
52W High
$1.94
Market Cap
$0.00B
Volume
2.67M
| -0.2 |
| 31 Dec 2021 | FY | 42.2% | -41.2% | -64.1% | -29.2% | 0.60 | 3.57 | -3.6 |
| 31 Dec 2020 | FY | 27.1% | -73.9% | -167.8% | -41.0% | 1.79 | 3.13 | -1.5 |
| 31 Dec 2019 | FY | 37.8% | -47.2% | -4736.1% | -56.1% | 36.59 | 1.05 | -0.7 |
| 31 Dec 2018 | FY | 36.6% | -46.6% | -194.0% | -55.9% | 0.98 | 2.09 | -0.9 |
| 31 Dec 2017 | FY | 32.2% | -35.9% | -57.6% | -39.2% | 0.00 | 2.70 | -1.9 |
| 31 Dec 2016 | FY | 39.2% | -29.7% | -69.7% | -36.6% | 0.01 | 1.89 | -5.5 |
| 31 Dec 2015 | FY | 32.9% | -41.8% | -81.4% | -48.0% | 0.01 | 2.30 | -2.4 |
| 31 Dec 2014 | FY | 38.1% | -39.7% | -45.0% | -31.9% | 0.00 | 3.39 | -6.3 |
| -0.3 |
| 31 Mar 2024 | Q1 | 32.9% | -64.0% | 335.3% | -18.9% | -9.13 | 1.17 | -0.1 |
| 31 Dec 2023 | Q4 | 26.1% | -39.5% | 2156.3% | -15.2% | -72.51 | 1.26 | -0.2 |
| 30 Sept 2023 | Q3 | 34.3% | -42.0% | -78.0% | -11.8% | 2.57 | 1.40 | -0.1 |
| 30 Jun 2023 | Q2 | 42.8% | -34.1% | -66.3% | -12.3% | 2.19 | 1.53 | -0.2 |
| 31 Mar 2023 | Q1 | 31.9% | -55.9% | -71.7% | -13.9% | 1.97 | 1.68 | -0.4 |
| 31 Dec 2022 | Q4 | 25.6% | -70.2% | -201.7% | -25.8% | 3.21 | 1.63 | -0.1 |
| 30 Sept 2022 | Q3 | 20.4% | -69.8% | -60.5% | -19.6% | 1.07 | 2.46 | -0.6 |
| 30 Jun 2022 | Q2 | 42.0% | -45.9% | -26.0% | -11.0% | 0.69 | 3.17 | -1.2 |